1. Has Received FDA Approval to Proceed with Its Streamlined Trial Protocol for the Next Stage of Pivotal U.S
https://www.magforce.com/en/news/?article=325.
2. “Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy”. This NoCanTher Project Has Received Funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 685795
https://cordis.europa.eu/project/id/685795
3. Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy (RADIOMAG)
www.cost-radiomag.eu/
4. Nanomedicine toward 2040
5. European Nanomedicine Characterization Lab
http://www.euncl.eu/